Lucid-MS, Quantum Biopharma's oral multiple sclerosis therapy candidate, was not toxic and had no side effects in healthy ...

Switching from one CD20-targeting therapy to another doesn't alter their ability to lower disease activity and slow ...

A study found neurofilament light chain at high levels in the blood and CSF of MS patients, suggesting its potential as a ...

Medications that promote repair of the myelin sheath that protects nerve cells may help limit damage due to MS, a trial ...

Columnist Desiree Lama describes her unexpected joy at having a new cat join her existing feline friend, especially when they ...

Women in their childbearing years are significantly less likely than men in the same age range to be given disease-modifying ...

Susan Payrovi, MD, and Mirla Avila, MD, discuss early gut microbiome formation and its lifelong influence on MS and immune ...

Three prevalent symptoms in MS – fatigue, mobility and cognitive impairment – generally aren't barriers to healthy habits, a ...

Columnist Susan Payrovi, MD, discusses the importance of prioritizing play. For her, it's a key source of physical and mental ...

Guest writer Denise Schnieders sounds the alarm as U.S. lawmakers continue to eliminate funding for key MS research programs.

A team of scientists analyzed data from over a dozen studies involving more than 900 people with MS to research iron rim ...

The effort to explore the genetic link between the Epstein-Barr virus and the risk of developing MS was awarded a $24,400 ...